stockportfolio.pro
Stocks / AORT vs NUTX
AORT vs NUTX
Artivion, Inc. and Nutex Health Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Artivion, Inc. (AORT) | Nutex Health Inc. (NUTX) | |
|---|---|---|
| Market cap | $1.0B | $1.0B |
| Revenue (latest FY) | $441.33M | $875.26M |
| Net income (latest FY) | $9.77M | $70.79M |
| Revenue growth (5y CAGR) | 11.8% | 26.1% |
| Net margin | 2.2% | 8.1% |
| Return on equity | 2.2% | 21.5% |
| P/E ratio | 82.3 | 10.1 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 4 | 5 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open AORT — free Open NUTX — freeFrequently asked questions
Which is bigger, AORT or NUTX?
Artivion, Inc. is larger by market capitalization — $1.0B versus $1.0B.
Which grows faster, AORT or NUTX?
Over the last five fiscal years, Nutex Health Inc. grew revenue faster — 26.1%/yr versus 11.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.